Furthermore, we demonstrate that CIP inhibits cardiac remodeling and protects the heart from HF after cardiac hypertrophy has been established, providing evidence of a role for CIP in cardiac hypertrophy and HF treatment. Here, MLIP is linked to cardiac hypertrophy.